Who to call at Genethon, and when

Fundz watches for the moments Genethon starts buying, and tells you who to reach.

An alert the day Genethon raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Genethon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genethon. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Genethon and Hansa Biopharma Launch Trial for Gene Therapy and Antibody Cleaving Enzyme Therapy Combination Treatment

Dec 03, 2024

Contract Type

partnership

RomeBiotechnologyHealth CareGeneticsTherapeutics

Description

Genethon and Hansa Biopharma have partnered to initiate a phase 2 clinical trial for a combination treatment of gene therapy and antibody cleaving enzyme therapy in Crigler-Najjar syndrome, aimed at addressing the challenge of preexisting antibodies inhibiting the activity of gene therapies.

Company Information

Company

Genethon

Location

Rome, Lazio, Italy

About

Généthon is a pioneer in the discovery and development of gene therapies for rare diseases, established by the AFM-Téléthon. The organization employs over 200 scientists and professionals dedicated to developing innovative therapies that improve the lives of patients with rare genetic diseases. It is known for its contributions to the field, including the first gene therapy for spinal muscular atrophy. Currently, Genethon has multiple products in clinical trials targeting various conditions.